SCHEMBL25697482

SCHEMBL25697482

CCOC(=O)C(C)(CCCC(=O)OC)C(C)=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.44
PKM P14618 3/20 0.42
THRB P10828 1/20 0.42
HTT P42858 1/20 0.41
MMP8 P22894 2/20 0.41
CYP4F2 P78329 2/20 0.39
CYP4A11 Q02928 2/20 0.39
MEN1 O00255 1/20 0.39
MAPT P10636 1/20 0.39
KMT2A Q03164 1/20 0.39
ATM Q13315 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CYP1A2 P05177 1/20 0.37
GAA P10253 2/20 0.37
KDM4E B2RXH2 1/20 0.37
MGAM O43451 1/20 0.35
SI P14410 1/20 0.35
MGAM2 Q2M2H8 1/20 0.35
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9263994 0.90 CYP1A2 (0.47) TSHRPKMTHRBHTTMMP8
SCHEMBL304464 0.84 CYP4F2 (0.46) TSHRPKMTHRBHTTMMP8
SCHEMBL10068075 0.83 CYP4F2 (0.41) TSHRPKMTHRBHTTMMP8
SCHEMBL25269898 0.83 TSHR (0.50) TSHRMEN1KMT2AL3MBTL1GAA
SCHEMBL13084351 0.81 MEN1 (0.47) TSHRPKMTHRBHTTMMP8
SCHEMBL1406283 0.81 CYP1A2 (0.52) TSHRPKMTHRBCYP4F2CYP4A11
SCHEMBL41296 0.80 MEN1 (0.46) TSHRPKMTHRBHTTMMP8
SCHEMBL10001105 0.80 MEN1 (0.54) PKMTHRBHTTMMP8CYP4F2
SCHEMBL1406347 0.79 TSHR (0.42) TSHRPKMTHRBHTTCYP4F2
SCHEMBL10001106 0.78 CYP4F2 (0.64) TSHRPKMTHRBHTTMMP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250163030-A1 PYRIDIZIN-3(2H)-ONE DERIVATIVES GILEAD SCIENCES, INC. 2025-05-22 US disclosed
EP-4423078-A1 PYRIDIZIN-3(2H)-ONE DERIVATIVES GILEAD SCIENCES, INC. (US) 2024-09-04 EP disclosed
CN-118139858-A Pyrazin-3 (2H) -one derivatives 吉利德科学公司 2024-06-04 CN disclosed
US-20230183216-A1 PYRIDIZIN-3(2H)-ONE DERIVATIVES GILEAD SCIENCES, INC. 2023-06-15 US disclosed
US-20230183216-A1 PYRIDIZIN-3(2H)-ONE DERIVATIVES GILEAD SCIENCES, INC. 2023-06-15 US disclosed
WO-2023076983-A1 PYRIDIZIN-3(2H)-ONE DERIVATIVES GILEAD SCIENCES, INC. (US) 2023-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250163030-A1 PYRIDIZIN-3(2H)-ONE DERIVATIVES PIR, CYP3A43, CYP1A2 TSHR 2222/4885PKM 891/4885THRB 3327/4885
US-20230183216-A1 PYRIDIZIN-3(2H)-ONE DERIVATIVES PIR, CYP3A43, CYP1A2 TSHR 2222/4885PKM 891/4885THRB 3327/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.